News Image

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Provided By GlobeNewswire

Last update: Aug 14, 2024

SAN DIEGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today reported financial results for the second quarter ended June 30, 2024, and provided recent business highlights.

Read more at globenewswire.com

TURNSTONE BIOLOGICS CORP

NASDAQ:TSBX (6/13/2025, 8:00:01 PM)

After market: 0.3393 +0 (+1.43%)

0.3345

-0.02 (-6.22%)



Find more stocks in the Stock Screener

TSBX Latest News and Analysis

ChartMill News Image11 days ago - ChartmillWhich stocks have an unusual volume on Wednesday?

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Mentions: MODV BMEA KPRX REVB ...

Follow ChartMill for more